JEWRAJ GOKLANI MAHESHWARI MD
Prescription History 1366431017
Internal Medicine - Medical Oncology in Owensboro, KY

NPI Status: Active since October 17, 2005

Contact Information

1000 BRECKENRIDGE ST STE 201
OWENSBORO, KY
ZIP 42303
Phone: (270) 688-3445
Fax: (270) 688-3344

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JEWRAJ GOKLANI MAHESHWARI MD, an active Medical Oncology specialist practicing in Owensboro, KY. Our medical registry currently tracks 58 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,677 documented patient claims. Among these therapy options, the most frequently utilized medication is Ondansetron Odt, which accounts for 360 claims alone.


Abiraterone Acetate

Generic Formulation: Abiraterone AcetateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
KY State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills33.1
Peer Average Days Supply963
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 65.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $74,868.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$6,806.22

State Avg Cost Per Claim

$4,372.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.

Therapeutic Applications

This medication is used to treat prostate cancer. Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children.

Acyclovir

Generic Formulation: AcyclovirSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 116
30-Day Fills 187.0
Days Supply 5,603
KY State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills31.0
Peer Average Days Supply776
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 452.4% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,265.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.53

State Avg Cost Per Claim

$21.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.

Therapeutic Applications

Acyclovir is used to treat infections caused by certain types of viruses. It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections.

Alprazolam

Generic Formulation: AlprazolamSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 104
30-Day Fills 104.0
Days Supply 2,140
KY State Average Benchmarks
Peer Average Claims81.0
Peer Average 30-Day Fills85.0
Peer Average Days Supply2,384
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 28.4% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $633.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.09

State Avg Cost Per Claim

$9.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)

Therapeutic Applications

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Amoxicillin-Clavulanate Potass

Generic Formulation: Amoxicillin/Potassium ClavSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 154
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.3
Peer Average Days Supply255
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $170.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.76

State Avg Cost Per Claim

$11.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.

Therapeutic Applications

Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Anastrozole

Generic Formulation: AnastrozoleSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 269
30-Day Fills 510.6
Days Supply 15,285
KY State Average Benchmarks
Peer Average Claims70.0
Peer Average 30-Day Fills151.0
Peer Average Days Supply4,493
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 284.3% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,426.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.89

State Avg Cost Per Claim

$24.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.

Therapeutic Applications

Anastrozole is used to treat breast cancer in women after menopause. Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers.

Bicalutamide

Generic Formulation: BicalutamideSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 19
30-Day Fills 23.0
Days Supply 690
KY State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills41.5
Peer Average Days Supply1,233
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $728.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.34

State Avg Cost Per Claim

$40.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bicalutamide is used to treat prostate cancer. This medication works by blocking the action of male hormones in the prostate, slowing the growth of cancer cells. This medication should not be used in women and children.

Bosulif

Generic Formulation: BosutinibSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 450
KY State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills14.8
Peer Average Days Supply440
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $299,078.25 across this reporting matrix range.

Provider Avg Cost Per Claim

$19,938.55

State Avg Cost Per Claim

$14,146.46

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bosutinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). It works by slowing or stopping the growth of cancer cells.

Brukinsa

Generic Formulation: ZanubrutinibSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 528
KY State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills16.1
Peer Average Days Supply480
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $256,404.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$14,244.68

State Avg Cost Per Claim

$13,338.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia). Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.

Cabometyx

Generic Formulation: Cabozantinib S-MalateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 870
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills20.9
Peer Average Days Supply617
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 45.0% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $823,878.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$28,409.61

State Avg Cost Per Claim

$24,777.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat various types of cancer (including kidney, thyroid, liver cancer). Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells.

Cefuroxime

Generic Formulation: Cefuroxime AxetilSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 34
30-Day Fills 34.0
Days Supply 241
KY State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills32.2
Peer Average Days Supply276
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $731.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.51

State Avg Cost Per Claim

$27.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cephalosporin antibiotic.

Therapeutic Applications

Cefuroxime is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Cephalexin

Generic Formulation: CephalexinSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 133
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills30.0
Peer Average Days Supply312
Conservative Utilization

This provider writes prescriptions for this formulation 32.1% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $152.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.04

State Avg Cost Per Claim

$7.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Dexamethasone

Generic Formulation: DexamethasoneSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 142
30-Day Fills 190.0
Days Supply 3,953
KY State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills30.7
Peer Average Days Supply369
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 389.7% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,356.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.59

State Avg Cost Per Claim

$13.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory 9-fluoro-glucocorticoid.

Therapeutic Applications

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Diazepam

Generic Formulation: DiazepamSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
KY State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills45.4
Peer Average Days Supply1,199
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 72.7% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $34.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.84

State Avg Cost Per Claim

$6.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

Therapeutic Applications

This medication is used to treat episodes of increased seizures (such as cluster or breakthrough seizures) in people who are already taking medications to control their seizures. This product is only recommended for short-term treatment of seizure attacks. It is not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious (possibly fatal) seizures that do not stop (status epilepticus). This medication is not recommended for children younger than 6 months of age because of the risk of serious side effects. Diazepam works by calming the brain and nerves. It belongs to a class of drugs known as benzodiazepines.

Diphenoxylate-Atropine

Generic Formulation: Diphenoxylate Hcl/AtropineSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 45
30-Day Fills 45.0
Days Supply 540
KY State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills22.9
Peer Average Days Supply430
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 114.3% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $922.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.50

State Avg Cost Per Claim

$36.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat diarrhea. It helps to decrease the number and frequency of bowel movements. It works by slowing the movement of the intestines. Diphenoxylate is similar to opioid pain relievers, but it acts mainly to slow the gut. Atropine belongs to a class of drugs known as anticholinergics, which help to dry up body fluids and also slow gut movement. This medication should not be used to treat diarrhea caused by certain types of infection (such as C. difficile-associated diarrhea following antibiotic therapy). Talk to your doctor for more details. This medication is not recommended for use in children younger than 6 years due to an increased risk of serious side effects (such as breathing problems).

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 17.0
Days Supply 510
KY State Average Benchmarks
Peer Average Claims61.0
Peer Average 30-Day Fills107.3
Peer Average Days Supply3,181
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.7% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $172.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.26

State Avg Cost Per Claim

$39.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Eliquis

Generic Formulation: ApixabanSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 91
30-Day Fills 98.3
Days Supply 2,944
KY State Average Benchmarks
Peer Average Claims83.0
Peer Average 30-Day Fills123.9
Peer Average Days Supply3,420
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $59,312.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$651.78

State Avg Cost Per Claim

$760.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Escitalopram Oxalate

Generic Formulation: Escitalopram OxalateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 17
30-Day Fills 27.0
Days Supply 788
KY State Average Benchmarks
Peer Average Claims55.0
Peer Average 30-Day Fills102.5
Peer Average Days Supply3,023
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.1% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $198.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.67

State Avg Cost Per Claim

$12.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

Therapeutic Applications

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness.

Exemestane

Generic Formulation: ExemestaneSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 63
30-Day Fills 92.0
Days Supply 2,735
KY State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills48.9
Peer Average Days Supply1,456
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 142.3% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,742.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$170.52

State Avg Cost Per Claim

$222.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age.

Fentanyl

Generic Formulation: FentanylSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 52
30-Day Fills 52.0
Days Supply 1,486
KY State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills34.3
Peer Average Days Supply934
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 52.9% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,647.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$108.61

State Avg Cost Per Claim

$101.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to cancer). Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Folic Acid

Generic Formulation: Folic AcidSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 12
30-Day Fills 26.0
Days Supply 780
KY State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills44.1
Peer Average Days Supply1,307
Conservative Utilization

This provider writes prescriptions for this formulation 45.5% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $22.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.91

State Avg Cost Per Claim

$5.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.

Therapeutic Applications

Folic acid is the man-made form of folate. Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects.

Furosemide

Generic Formulation: FurosemideSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 66
30-Day Fills 84.0
Days Supply 2,508
KY State Average Benchmarks
Peer Average Claims99.0
Peer Average 30-Day Fills179.6
Peer Average Days Supply5,169
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $225.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.41

State Avg Cost Per Claim

$4.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.

Therapeutic Applications

Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Gabapentin

Generic Formulation: GabapentinSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 86
30-Day Fills 95.0
Days Supply 2,794
KY State Average Benchmarks
Peer Average Claims162.0
Peer Average 30-Day Fills192.6
Peer Average Days Supply5,572
Conservative Utilization

This provider writes prescriptions for this formulation 46.9% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $693.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.06

State Avg Cost Per Claim

$15.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 291
30-Day Fills 291.0
Days Supply 4,102
KY State Average Benchmarks
Peer Average Claims147.0
Peer Average 30-Day Fills148.0
Peer Average Days Supply3,431
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 98.0% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,250.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.48

State Avg Cost Per Claim

$22.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Hydroxyurea

Generic Formulation: HydroxyureaSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 101
30-Day Fills 185.4
Days Supply 5,545
KY State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills59.0
Peer Average Days Supply1,742
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 206.1% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,991.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.52

State Avg Cost Per Claim

$33.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.

Therapeutic Applications

This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas).

Ibrance

Generic Formulation: PalbociclibSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 34
30-Day Fills 34.0
Days Supply 952
KY State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.1
Peer Average Days Supply729
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 30.8% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $563,983.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$16,587.75

State Avg Cost Per Claim

$14,823.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Palbociclib is used to treat a certain type of breast cancer. It works by slowing or stopping the growth of cancer cells.

Imatinib Mesylate

Generic Formulation: Imatinib MesylateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 52
30-Day Fills 52.0
Days Supply 1,560
KY State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.9
Peer Average Days Supply681
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 136.4% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $48,204.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$927.00

State Avg Cost Per Claim

$2,740.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

Therapeutic Applications

This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome).

Imbruvica

Generic Formulation: IbrutinibSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 28
30-Day Fills 28.0
Days Supply 784
KY State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills35.6
Peer Average Days Supply1,004
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $443,872.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$15,852.61

State Avg Cost Per Claim

$14,706.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).

Jakafi

Generic Formulation: Ruxolitinib PhosphateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
KY State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills23.8
Peer Average Days Supply713
Conservative Utilization

This provider writes prescriptions for this formulation 47.8% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $224,039.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$18,669.98

State Avg Cost Per Claim

$16,389.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system).

Letrozole

Generic Formulation: LetrozoleSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 293
30-Day Fills 637.5
Days Supply 18,989
KY State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills112.8
Peer Average Days Supply3,371
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 452.8% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,072.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$48.03

State Avg Cost Per Claim

$39.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.

Therapeutic Applications

This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers.

Levofloxacin

Generic Formulation: LevofloxacinSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 92
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.4
Peer Average Days Supply238
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $61.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.75

State Avg Cost Per Claim

$8.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The L-isomer of Ofloxacin.

Therapeutic Applications

This medication is used to treat a variety of bacterial infections. Levofloxacin belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. Levofloxacin injection is used if you cannot take the medication by mouth. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 73
30-Day Fills 156.0
Days Supply 4,680
KY State Average Benchmarks
Peer Average Claims174.0
Peer Average 30-Day Fills360.1
Peer Average Days Supply10,609
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.0% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $735.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.07

State Avg Cost Per Claim

$15.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Lidocaine-Prilocaine

Generic Formulation: Lidocaine/PrilocaineSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 350
KY State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills23.7
Peer Average Days Supply566
Conservative Utilization

This provider writes prescriptions for this formulation 31.8% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $212.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.18

State Avg Cost Per Claim

$21.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION.

Therapeutic Applications

This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts).

Lorazepam

Generic Formulation: LorazepamSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 27
30-Day Fills 27.0
Days Supply 283
KY State Average Benchmarks
Peer Average Claims55.0
Peer Average 30-Day Fills58.0
Peer Average Days Supply1,495
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 50.9% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $64.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.38

State Avg Cost Per Claim

$7.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Therapeutic Applications

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Megestrol Acetate

Generic Formulation: Megestrol AcetateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 42
30-Day Fills 48.0
Days Supply 1,340
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills24.1
Peer Average Days Supply640
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 110.0% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,936.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$69.91

State Avg Cost Per Claim

$66.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

Therapeutic Applications

Megestrol is used to treat loss of appetite and weight loss in people with AIDS. Improving your appetite and gaining weight may help you feel better and be more active. Megestrol is similar to a natural substance made by the body called progesterone.

Methylprednisolone

Generic Formulation: MethylprednisoloneSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 63
30-Day Fills 63.0
Days Supply 379
KY State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills39.8
Peer Average Days Supply250
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 61.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $573.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.10

State Avg Cost Per Claim

$8.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A PREDNISOLONE derivative with similar anti-inflammatory action.

Therapeutic Applications

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Morphine Sulfate Er

Generic Formulation: Morphine SulfateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
KY State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills53.2
Peer Average Days Supply1,529
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.5% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $287.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.11

State Avg Cost Per Claim

$37.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Nystatin

Generic Formulation: NystatinSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 318
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills29.2
Peer Average Days Supply479
Conservative Utilization

This provider writes prescriptions for this formulation 42.9% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $407.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.44

State Avg Cost Per Claim

$21.89

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.

Therapeutic Applications

Nystatin is used to treat fungal skin infections. Nystatin is an antifungal that works by stopping the growth of fungus.

Ondansetron Hcl

Generic Formulation: Ondansetron HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 27
30-Day Fills 27.0
Days Supply 254
KY State Average Benchmarks
Peer Average Claims75.0
Peer Average 30-Day Fills75.4
Peer Average Days Supply1,154
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.0% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $231.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.56

State Avg Cost Per Claim

$62.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Ondansetron Odt

Generic Formulation: OndansetronSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 360
30-Day Fills 360.0
Days Supply 3,983
KY State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.8
Peer Average Days Supply310
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 1,185.7% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,919.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.00

State Avg Cost Per Claim

$22.84

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Therapeutic Applications

This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 45
30-Day Fills 45.0
Days Supply 716
KY State Average Benchmarks
Peer Average Claims71.0
Peer Average 30-Day Fills71.8
Peer Average Days Supply1,527
Conservative Utilization

This provider writes prescriptions for this formulation 36.6% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $973.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.63

State Avg Cost Per Claim

$22.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 60
30-Day Fills 60.0
Days Supply 1,063
KY State Average Benchmarks
Peer Average Claims117.0
Peer Average 30-Day Fills117.6
Peer Average Days Supply2,841
Conservative Utilization

This provider writes prescriptions for this formulation 48.7% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,747.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.13

State Avg Cost Per Claim

$34.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 14
30-Day Fills 23.0
Days Supply 690
KY State Average Benchmarks
Peer Average Claims103.0
Peer Average 30-Day Fills198.5
Peer Average Days Supply5,880
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.4% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $108.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.75

State Avg Cost Per Claim

$13.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Pomalyst

Generic Formulation: PomalidomideSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 336
KY State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills19.5
Peer Average Days Supply539
Conservative Utilization

This provider writes prescriptions for this formulation 36.8% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $241,782.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$20,148.53

State Avg Cost Per Claim

$20,163.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Pomalidomide is used to treat certain types of cancers (such as multiple myeloma, Kaposi sarcoma). It works by slowing or stopping the growth of cancer cells.

Potassium Chloride

Generic Formulation: Potassium ChlorideSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 38
30-Day Fills 50.5
Days Supply 1,415
KY State Average Benchmarks
Peer Average Claims82.0
Peer Average 30-Day Fills142.6
Peer Average Days Supply4,127
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.7% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $922.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.29

State Avg Cost Per Claim

$25.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.

Therapeutic Applications

This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics.

Prednisone

Generic Formulation: PrednisoneSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 66
30-Day Fills 69.0
Days Supply 1,806
KY State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills60.8
Peer Average Days Supply969
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $309.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.70

State Avg Cost Per Claim

$5.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Prochlorperazine Maleate

Generic Formulation: Prochlorperazine MaleateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 324
30-Day Fills 327.0
Days Supply 3,357
KY State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills33.2
Peer Average Days Supply446
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 912.5% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,399.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.67

State Avg Cost Per Claim

$18.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)

Therapeutic Applications

This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery.

Promethazine Hcl

Generic Formulation: Promethazine HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 21
30-Day Fills 21.0
Days Supply 197
KY State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills36.6
Peer Average Days Supply498
Conservative Utilization

This provider writes prescriptions for this formulation 40.0% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $94.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.48

State Avg Cost Per Claim

$11.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. Promethazine is used to prevent and treat nausea and vomiting related to certain conditions (such as motion sickness, or before/after surgery). It is also used to treat allergy symptoms such as rash, itching, and runny nose. It may be used to help you feel sleepy/relaxed before and after surgery or to help certain opioid pain relievers (such as meperidine) work better. The suppository form is used when medications cannot be taken by mouth. Promethazine is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Its other effects (such as anti-nausea, calming, pain relief) may work by affecting other natural substances (such as acetylcholine) and by acting directly on certain parts of the brain.

Revlimid

Generic Formulation: LenalidomideSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 56
30-Day Fills 56.0
Days Supply 1,463
KY State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills38.6
Peer Average Days Supply1,027
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 47.4% more claims than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $976,321.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$17,434.30

State Avg Cost Per Claim

$18,272.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.

Therapeutic Applications

Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication.

Sertraline Hcl

Generic Formulation: Sertraline HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 19
30-Day Fills 23.0
Days Supply 690
KY State Average Benchmarks
Peer Average Claims72.0
Peer Average 30-Day Fills127.3
Peer Average Days Supply3,745
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 73.6% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $94.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.99

State Avg Cost Per Claim

$9.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Sulfamethoxazole-Trimethoprim

Generic Formulation: Sulfamethoxazole/TrimethoprimSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 27
30-Day Fills 28.0
Days Supply 834
KY State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills26.9
Peer Average Days Supply321
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $144.22 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.34

State Avg Cost Per Claim

$5.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Therapeutic Applications

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Tagrisso

Generic Formulation: Osimertinib MesylateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
KY State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.9
Peer Average Days Supply687
Conservative Utilization

This provider writes prescriptions for this formulation 40.9% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $225,885.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$17,375.79

State Avg Cost Per Claim

$17,056.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat lung cancer. Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.

Tamoxifen Citrate

Generic Formulation: Tamoxifen CitrateSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 142
30-Day Fills 311.0
Days Supply 9,288
KY State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills81.5
Peer Average Days Supply2,434
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 273.7% higher than the standard regional baseline profile for KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,408.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.09

State Avg Cost Per Claim

$32.70

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

Therapeutic Applications

Tamoxifen is used to treat breast cancer. It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue.

Tasigna

Generic Formulation: Nilotinib HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 308
KY State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills15.9
Peer Average Days Supply443
Conservative Utilization

This provider writes prescriptions for this formulation 26.7% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $222,910.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$20,264.56

State Avg Cost Per Claim

$16,547.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Nilotinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). It works by slowing or stopping the growth of cancer cells.

Temazepam

Generic Formulation: TemazepamSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 30
30-Day Fills 32.0
Days Supply 950
KY State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills31.6
Peer Average Days Supply925
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $274.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.16

State Avg Cost Per Claim

$10.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.

Therapeutic Applications

This medication is used to treat a certain sleep problem (insomnia). It may help you fall asleep faster, stay asleep longer, and lessen how often you wake up during the night, so you can get a better night's rest. Temazepam belongs to a class of drugs called benzodiazepines. It acts on your brain to produce a calming effect. Use of this medication is usually limited to short treatment periods of 1 to 2 weeks or less. If your insomnia continues for a longer time, talk to your doctor to see if you need other treatment.

Valacyclovir

Generic Formulation: Valacyclovir HclSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 23
30-Day Fills 33.0
Days Supply 887
KY State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills28.8
Peer Average Days Supply608
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $984.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$42.80

State Avg Cost Per Claim

$41.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES.

Therapeutic Applications

Valacyclovir is used to treat infections caused by certain types of viruses. In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal.

Venclexta

Generic Formulation: VenetoclaxSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 627
KY State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills20.2
Peer Average Days Supply580
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $168,565.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$7,662.08

State Avg Cost Per Claim

$8,854.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells.

Warfarin Sodium

Generic Formulation: Warfarin SodiumSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 26
30-Day Fills 46.4
Days Supply 1,392
KY State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills88.4
Peer Average Days Supply2,535
Conservative Utilization

This provider writes prescriptions for this formulation 45.8% less frequently than the standard regional baseline metric for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $389.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.99

State Avg Cost Per Claim

$9.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.

Therapeutic Applications

This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a blood thinner, but the more correct term is anticoagulant. It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood.

Xarelto

Generic Formulation: RivaroxabanSpecialty: Hematology-Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 15.0
Days Supply 450
KY State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills76.9
Peer Average Days Supply2,170
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 71.7% less volume than the regional standard for practitioners inside KY. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,698.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$669.14

State Avg Cost Per Claim

$853.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Therapeutic Applications

Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like JEWRAJ GOKLANI MAHESHWARI MD provides transparency into local medical care patterns within Owensboro, KY.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Medical Oncology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.